AcelRx Pharmaceuticals (ACRX) Reports In-Line Q2 Loss of 22c/Share
Tweet Send to a Friend
AcelRx Pharmaceuticals (NASDAQ: ACRX) reported Q2 EPS of ($0.22) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
